Back to Press Releases  |  Previous  |  Next

QBC Diagnostics in Attendance at COLA Symposium

Baltimore, Maryland, April 21, 2010 -  QBC Diagnostics is pleased to announce that it will be in attendance at the COLA Symposium for Clinical Laboratories at the Hilton Baltimore Inner Harbor Hotel.

QBC Diagnostics offers the world's only true dry hematology systems, the STAR and the Autoread, which are designed for the point-of-care setting.  This marks the third year that the company will be in attendance at the COLA Symposium, which is designed to provide education for laboratory managers and technicians.

Craig Stout, QBC Diagnostics General Manager and Vice President, said, "Meeting CLIA standards is critical for all labs looking to bring the benefits of hematology analysis to patients.  Attending this show demonstrates our continued commitment to providing products that continue to meet and exceed these exacting standards."

QBC Diagnostics can be found at Booth #113 at the COLA Symposium.

Next: QBC Diagnostics Introduces the ParaLens/QBC Malaria Test Application Note

About QBC Diagnostics
QBC Diagnostics is a privately held company headquartered in Port Matilda, Pennsylvania.  The company manufactures a line of complete blood count analyzers and fluorescence microscopy products.  Additional information can be found by visiting the company website (www.qbcdiagnostics.com) or by calling 877-231-3115.  Follow QBC on Twitter or Facebook for further updates.